DMK PHARMACEUTICALS CORP COM USD0.0001 (POST REV SPLIT) financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A4X for the last quarter is 9.06 k USD, and it's 30.48% higher compared to the previous quarter. The net income of Q3 23 is -1.39 M USD.